|
Two
studies that examined the link between coffee drinking and cancer
found some interesting results: Drinking coffee daily was linked
to a decreased risk of liver cancer, and drinking coffee or tea
was not associated with the risk of colorectal cancer.
Coffee and Liver Cancer
In the first study, researchers looked at the association between
coffee consumption and liver cancer among middle-aged and elderly
people in Japan. Those who drank coffee daily, or close to it, had
about half the risk of hepatocellular carcinoma (HCC), a type of
liver cancer, than people who never drank coffee.
Specifically, among daily coffee drinkers the liver cancer rate
was over 200 cases per 100,000 people over 10 years. Among those
who never drank coffee the rate rose to nearly 550 cases per 100,000
people. And, the more coffee that was consumed, the lower the HCC
risk went.
Past studies have also suggested that drinking coffee may decrease
the risk of HCC, but researchers cautioned that, since no distinction
was made between caffeinated and decaffeinated coffee, the latter
of which is rarely consumed in Japan, the results don’t necessarily
indicate that caffeine was responsible for the protective effect.
Coffee and Colorectal Cancer
The second study involved data from two large prospective studies
to explore the link between coffee, tea and caffeine and colorectal
cancer during close to 2 million person-years of follow-up. Among
people who drank caffeinated coffee or tea, no association was found
with colon or rectal cancers.
However, those who drank two or more cups per day of decaffeinated
coffee had about half the risk of rectal cancer (12 cases per 100,000
person-years of follow-up) as those who never drank decaffeinated
coffee (19 cases of rectal cancer per 100,000 person-years of follow-up).
The researchers pointed out that the association might be due to
other lifestyle factors, as people who drink decaffeinated coffee
may be more health conscious in general than those who drink caffeinated
coffee.
News-Medical.net
February 15, 2005
Journal
of the National Cancer Institute February 16, 2005;97(4):282-292
Journal
of the National Cancer Institute February 16, 2005;97(4):293-300
|